Stay updated with breaking news from Peter Guenter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Annual Shareholders' Meeting Results On April 25, 2023, Galapagos NV held its Annual Shareholders' Meeting . The meeting minutes and other documentation... | April 25, 2023
Mechelen, Belgium; 25 April 2023, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces the approval of all resolutions proposed at its annual shareholders' meeting (AGM)
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer.
Publication of annual report for financial year 2022Annual Shareholders' Meeting proposed resolutions include re-appointment of Board members and appointment of new statutory auditor Mechelen
Investegate announcements from Galapagos NV, Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting